Sichuan Goldstone Asia Pharmaceutical Inc. (300434.SZ)
300434.SZ Stock Price Chart
Explore Sichuan Goldstone Asia Pharmaceutical Inc. interactive price chart. Choose custom timeframes to analyze 300434.SZ price movements and trends.
300434.SZ Company Profile
Discover essential business fundamentals and corporate details for Sichuan Goldstone Asia Pharmaceutical Inc. (300434.SZ) to support your stock research and investment decisions.
Sector
Industrials
Industry
Industrial - Distribution
IPO Date
30 Apr 2015
Employees
1.94K
Website
https://www.goldstone-group.comCEO
Yiping Ma
Description
Sichuan Goldstone Asia Pharmaceutical Inc. engages in the research, development, manufacture, and sale of medicines and health products in China and internationally. The company offers various pharmaceutical preparations and APIs; Chinese and western pharmaceutical preparations and raw materials; and tablets, capsules, dietary supplements, vitamin products, OTC products, and prescription drugs. It also trades in various pharmaceutical products, such as Chinese herbal medicine materials, Chinese patent medicines, Chinese herbal pieces, chemical raw materials, pharmaceutical preparations, antibiotic preparations, biochemical drugs, dietary supplements, and toxic drugs for medical use, medical devices, etc.; and sells adult drug products under the Quike brand and children's general medicine products under the Mini-Quike brand name. In addition, the company researches, develops, manufactures, and sells plastic composite pipe and vacuum coating machines. Further, it offers reinforced pipe equipment, such as steel reinforced corrugated pipes, reinforced composite polyethylene pipes, fiberglass reinforced RTP pipes, steel reinforced large diameter pipes, steel reinforced corrugated pipe socket and spigot making machines, abrasion resistant industries pipes, extrusion pipe fittings, and perforated steel reinforced polyethylene composite pipes. Additionally, the company provides vacuum coating equipment, including low-emissivity glass coating lines, reflect glass magnetron sputtering coating lines, magnetron sputtering mirror coating production lines, vacuum sputter systems for automotive car mirrors, ITO/TCO glass coating machines, sputtering metallization machines, optical lens coating machines, roll web metallization machines, and air-to-air solar absorption strip sputtering production line; and smart parking equipment. Sichuan Goldstone Asia Pharmaceutical Inc. was founded in 2001 and is based in Chengdu, China.
300434.SZ Financial Timeline
Browse a chronological timeline of Sichuan Goldstone Asia Pharmaceutical Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Dividend declared on 19 Jun 2025
A dividend of ¥0.07 per share was announced, adjusted to ¥0.07. The dividend was paid on 19 Jun 2025.
Earnings released on 23 May 2025
EPS came in at ¥0.08 , while revenue for the quarter reached ¥345.71M .
Earnings released on 31 Mar 2025
EPS came in at ¥0.16 , while revenue for the quarter reached ¥291.49M .
Earnings released on 30 Sept 2024
EPS came in at ¥0.05 , while revenue for the quarter reached ¥234.72M .
Earnings released on 30 Jun 2024
EPS came in at -¥0.13 , while revenue for the quarter reached ¥159.14M .
Dividend declared on 28 Jun 2024
A dividend of ¥0.11 per share was announced, adjusted to ¥0.11. The dividend was paid on 28 Jun 2024.
Earnings released on 24 May 2024
EPS came in at -¥0.03 , while revenue for the quarter reached ¥382.14M .
Earnings released on 31 Mar 2024
EPS came in at ¥0.22 , while revenue for the quarter reached ¥357.49M .
Earnings released on 30 Sept 2023
EPS came in at -¥0.04 , while revenue for the quarter reached ¥193.34M .
Earnings released on 30 Jun 2023
EPS came in at ¥0.03 , while revenue for the quarter reached ¥213.94M .
Earnings released on 31 Mar 2023
EPS came in at ¥0.36 , while revenue for the quarter reached ¥419.79M .
Earnings released on 1 Jan 2023
EPS came in at ¥0.26 , while revenue for the quarter reached ¥531.16M .
Earnings released on 30 Sept 2022
EPS came in at ¥0.06 , while revenue for the quarter reached ¥232.01M .
Earnings released on 30 Jun 2022
EPS came in at ¥0.04 , while revenue for the quarter reached ¥164.45M .
Earnings released on 31 Mar 2022
EPS came in at ¥0.17 , while revenue for the quarter reached ¥314.99M .
Earnings released on 31 Dec 2021
EPS came in at -¥0.04 , while revenue for the quarter reached ¥321.58M .
Earnings released on 30 Sept 2021
EPS came in at ¥0.02 , while revenue for the quarter reached ¥196.39M .
Earnings released on 30 Jun 2021
EPS came in at -¥0.01 , while revenue for the quarter reached ¥158.66M .
Earnings released on 26 Apr 2021
EPS came in at -¥1.41 , while revenue for the quarter reached ¥293.03M .
Earnings released on 31 Mar 2021
EPS came in at ¥0.20 , while revenue for the quarter reached ¥376.88M .
Earnings released on 30 Sept 2020
EPS came in at -¥0.25 , while revenue for the quarter reached ¥147.01M .
300434.SZ Stock Performance
Access detailed 300434.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.